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Central insulin receptor-mediated signaling is attracting the growing attention of
researchers because of rapidly accumulating evidence implicating it in the mechanisms
of plasticity, stress response, and neuropsychiatric disorders including depression.
Dicholine succinate (DS), a mitochondrial complex II substrate, was shown to enhance
insulin-receptor mediated signaling in neurons and is regarded as a sensitizer of the
neuronal insulin receptor. Compounds enhancing neuronal insulin receptor-mediated
transmission exert an antidepressant-like effect in several pre-clinical paradigms of
depression; similarly, such properties for DS were found with a stress-induced anhedonia
model. Here, we additionally studied the effects of DS on several variables which
were ameliorated by other insulin receptor sensitizers in mice. Pre-treatment with
DS of chronically stressed C57BL6 mice rescued normal contextual fear conditioning,
hippocampal gene expression of NMDA receptor subunit NR2A, the NR2A/NR2B ratio
and increased REM sleep rebound after acute predation. In 18-month-old C57BL6 mice,
a model of elderly depression, DS restored normal sucrose preference and activated
the expression of neural plasticity factors in the hippocampus as shown by Illumina
microarray. Finally, young naïve DS-treated C57BL6 mice had reduced depressive- and
anxiety-like behaviors and, similarly to imipramine-treated mice, preserved hippocampal
levels of the phosphorylated (inactive) form of GSK3 beta that was lowered by forced
swimming in pharmacologically naïve animals. Thus, DS can ameliorate behavioral and
molecular outcomes under a variety of stress- and depression-related conditions. This
further highlights neuronal insulin signaling as a new factor of pathogenesis and a potential
pharmacotherapy of affective pathologies.
Keywords: chronic stress, insulin receptor, dicholine succinate, phosphorylated glycogen synthase kinase-3beta
(pGSK-3beta), NMDA receptor subunits NR2A and NR2B, sleep EEG, aging, hippocampal plasticity
INTRODUCTION
Central insulin receptor signaling is important in brain func-
tion/dysfunction including cognitive disorders, stress response,
and depression. As a member of a subfamily of receptor tyro-
sine kinases, the neuronal insulin receptor has been shown to
be involved in synaptic plasticity, cell differentiation, myelina-
tion, and survival (Chiu et al., 2008; Huang et al., 2010a; Lin
et al., 2010) and metabolic processes (Govind et al., 2001; Zhao
and Alkon, 2001; Freude et al., 2008). Insulin signaling has
been found to regulate dopamine-mediated neurotransmission
(Williams et al., 2007) and extracellular levels of norepinephrine
and serotonin (Daws et al., 2009). The robust density of the neu-
ronal insulin receptor in the hippocampus and cerebral cortex
(Mufson et al., 1999; Sun et al., 2010) and its high structural
homology in the activation loop segment with TrkB suggest its
role in stress response (Krishnan et al., 2007; Kikusui et al., 2009;
Spencer et al., 2010). Compromised insulin signaling can result
in cognitive deficits (van der Heide et al., 2006; Kuhad et al.,
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2009), neurodegeneration (Pomytkin, 2012) and depressive-like
syndrome (Banks et al., 2012; Gold et al., 2013; Pan et al., 2013).
The latest clinical and translational studies have revealed
antidepressant-like effects, increased neuronal mitochondrial
biogenesis, decreased neuronal damage and anti-inflammatory
properties for compounds that potentiate the binding of insulin
to its receptor or its immediate molecular consequences via var-
ious mechanisms and are therefore called “sensitizers of the
neuronal insulin receptor” (Storozhevykh et al., 2007; Igarashi
et al., 2008; Storozheva et al., 2008; Eissa Ahmed and Al-Rasheed,
2009; Mittal et al., 2009; Rasgon et al., 2010; Kemp et al., 2011).
Such effects were reported for the thiazolidinediones rosiglita-
zone and pioglitazone (Saubermann et al., 2002; Ali et al., 2006;
Zhao et al., 2006; Asghar et al., 2007; Strum et al., 2007; Eissa
Ahmed and Al-Rasheed, 2009; Mittal et al., 2009; Rasgon et al.,
2010; Kemp et al., 2011). For instance, rosiglitazone, one of
the insulin sensitizers of the thiazolidinedione class, induces an
antidepressant-like effect in the tail suspension and forced swim
tests in mice, reducing immobilization and floating behavior
(Eissa Ahmed and Al-Rasheed, 2009). Similar effects were found
for pioglitazone, another insulin receptor sensitizer, which were
shown to be NMDA receptor-dependent (Salehi-Sadaghiani et al.,
2012; Sharma et al., 2012). Rosiglitazone and pioglitazone were
reported to be effective in the treatment of major depressive dis-
order that was refractory to standard antidepressant treatment
and accompanied by insulin resistance (Rasgon et al., 2010; Kemp
et al., 2011).
The antidepressant-like effects were also reported for a mito-
chondrial complex II substrate, Dicholine Succinate (DS) (Cline
et al., 2012; Costa-Nunes et al., 2012, 2015). DS was found
to dose-dependently stimulate insulin-dependent H2O2 produc-
tion of the mitochondrial respiratory chain in cerebellar neurons
leading to an enhancement of the insulin receptor via insulin-
stimulated autophosphorylation of the insulin receptor kinase at
tyrosine residues in neurons, which is a key regulatory event of the
insulin receptor function. The effect of DS is dependent on the
presence of insulin (Storozhevykh et al., 2007; Storozheva et al.,
2008; Shomaker et al., 2010; Persiyantseva et al., 2013).
Our previous studies utilizing a mouse depression model
where a depressive-like state is induced by chronic stress and
defined by a reduction in reward sensitivity, anhedonia, showed
the antidepressant- and anti-anxiety effects of DS in CD1 mice
(Cline et al., 2012). As for instance, chronic intraperitoneal
administration of DS for 7 days, at 25mg/kg/day before the onset
of a 10-day stress, rescued normal sucrose preference, floating and
step-down avoidance learning, as well as hippocampal expression
of Insulin-like Growth Factor 2 (IGF-2), a member of the insulin
gene family with neurotrophic properties (Chen et al., 2011;
Bracko et al., 2012; Basta-Kaim et al., 2014). In other experiments,
administration of DS for 7 days in mice at similar doses res-
cued aging-related decreases of brain N-acetylaspartate/creatine,
a marker of neuronal function and viability and the acquisition
of hippocampus-dependent tasks in rat models of chronic cere-
bral hypoperfusion and beta-amyloid peptide-(25–35)-induced
toxicity (Storozheva et al., 2008).
Meanwhile, the antidepressant effects of DS were not assessed
in other than chronic stress depression model, e.g., in models that
mimic a state of learned helplessness which is distinct from hedo-
nic deficit and an important feature of depression (Porsolt and
Papp, 1998). Moreover, the possibility might exist that the antide-
pressant effects of DS could be limited by the conditions induced
by stress and will not preclude other origins/manifestations of a
depressive-like syndrome. However, the above mentioned efficacy
of other insulin receptor sensitizers with regard to measures of
helpless behavior, e.g., in the tail suspension and forced swim test,
and the ameliorative effects of DS in aged rodents suggest the effi-
cacy of DS in a variety of experimental conditions. Based on this,
the current study’s objectives were to examine the effects of DS on
several behavioral, molecular and EEG variables that were previ-
ously characterized as biological correlates of depressive state and
adaptive response to stress in mice.
In the first experiment, using a model of stress-induced anhe-
donia (Strekalova and Steinbusch, 2010; Costa-Nunes et al., 2014;
Cline et al., 2015) we investigated whether a pre-treatment in
C57BL6J mice with DS, at the dose of 25mg/kg/day intraperi-
toneally for 7 days, would improve normal sleep rebound (aug-
mentation) following acute stress, a sign of adaptive stress
response (Marinesco et al., 1999; Suchecki et al., 2012; Albu
et al., 2014; Keshavarzy et al., 2014), as well as contextual
fear conditioning learning that is regarded to be related to the
adaptive sleep function (Rolls et al., 2013; Barnes and Wilson,
2014). Also, we studied hippocampal gene expression of NMDA
receptor subunit NR2A and the ratio of NR2A/NR2B, whose
increases were previously demonstrated to accompany a devel-
opment of stress-induced anhedonia in the here applied chronic
stress model (Costa-Nunes et al., 2014). Notably, changes in the
NMDA-receptor mediated transmission were shown to under-
lie the antidepressant effects of the neuronal insulin sensitizer
pioglitazone (Salehi-Sadaghiani et al., 2012).
Next, we have examined the potential antidepressant-like
effects of DS in a recently validated model of elderly depression,
where naïve 18-month-old C57BL6 exhibit hedonic deficit in a
sucrose test, which is reversible by drugs with antidepressant and
neuroprotective activity (Malatynska et al., 2012). The effects of
7-day intraperitoneal injections of DS at the dose of 25mg/kg/day
to aged mice were assessed in the sucrose test and Illumina assay
of gene expression profiling of the hippocampus and prefrontal
cortex.
Finally, we applied a 2-week administration of DS via drink-
ing water at two doses of 25 and 75mg/kg/day, in young naïve
C57BL6J mice, and tested them in 2-day forced swim test. The
latter treatment group of mice was also investigated in the novel
cage and elevated O-maze, to assess potential changes in their
depressive- and anxiety-like behaviors, as well as locomotion /
exploration. A 2-week dosing with imipramine via drinking water
(2.5 and 15mg/kg/day) was used as a reference antidepressant
treatment in the forced swim test. Additionally, hippocampal lev-
els of the phosphorylated (inactive) form of Glycogen synthase
kinase-3beta (pGSK3 beta), a previously determined marker of
depressive-like behavior and antidepressant activity in the forced
swim test (Markova et al., 2013a, 2014), were evaluated after
the exposure of mice to forced swimming and treatment with
DS at the dose of 75mg/kg/day or imipramine at the dose of
15mg/kg/day.
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MATERIALS AND METHODS
ANIMALS
Studies were performed using 3.5-month-old male C57BL/6J
mice. 3.5-month-old male CD1 mice were used for resident-
intruder for social defeat paradigms and 2-5-month-old Wistar
rats were used for predator stress. All animals were from the
Gulbenkian Institute of Science, Oeiras, Portugal. C57BL/6J mice
were housed individually for 14 days before the start of experi-
ments; CD1 mice and rats were housed in groups of five before
the experiment and then individually. All animals were under a
reversed 12-h light–dark cycle (lights on: 21:00 h) starting from
the day of animals’ transportation in the laboratory, with food
and water ad libitum, under controllable laboratory conditions
(22 ± 1◦C, 55% humidity).
All studies were carried out in accordance with the European
Communities Council Directive for the care and use of lab-
oratory animals. A license BH-2007 had been issued by
the Ethics Committee on Animal Experimentation of Claude
Bernard University of Lyon, in compliance with the decree No.:
03-505-2008 of the French Agriculture Ministry; permission
0421/000/000/2013 was issued by General Directory of Ethical
Committee of the New University of Lisbon, in accordance
with Portuguese Law-Decrees DL129/92 (July 6th), DL197/96
(October 16th) and Ordinance Port.131/97 (November 7th).
This study had been also approved by the ethics committee
of Maastricht University for animal research: CPV, DEC-UM
2009-109.
STUDY DESIGN WITH CHRONIC STRESS DEPRESSION MODEL AND
EEG ANALYSIS OF SLEEP
Chronic Stress Procedure and Behavioral Testing: Chronic stress
and behavioral tests associated with its analysis were performed as
described previously (Strekalova et al., 2011, 2013, 2015; Couch
et al., 2013). Mice assigned to the stress group were injected with
DS (n = 20; 25mg/kg/day, i.p.) or vehicle (n = 19; see below)
during 1 week prior the stress procedure as described elsewhere
(Cline et al., 2012). Control mice (n = 7) were not treated.
Animals were assigned to three experimental conditions and had
similar body weight and baseline sucrose preference (Figure 2A).
Briefly, animals were exposed to 10 days of chronic unpredictable
stress followed by behavioral testing using a two-bottle sucrose
preference test (performed on Day 11; see below), as well as a
contextual fear conditioning learning task (performed on Days 12
and 13) that was carried out as described previously (Strekalova
et al., 2003; Vignisse et al., 2014; see below). Twenty four hours
after the termination of behavioral testing, on Day 14, a frac-
tion of stressed vehicle- (n = 8), DS-treated (n = 6) and control
(n = 7) mice, were sacrificed for brain dissection and subse-
quent RT PCR analysis of NMDA receptor subunits NR2A and
NR2B. Another fraction of stressed vehicle- (n = 7), DS-treated
(n = 6) mice were subjected to a sleep rebound paradigm and
EEG recording (see below, Figure 1A). Remaining mice were used
for other assays not reported in the current work. In addition,
non-stressed mice that either received DS or not (n = 15 in each
group) were studied in a sucrose preference test before and after
10 days following the dosing with DS was performed as described
above.
The chronic stress procedure employed in this study com-
prised night time rat exposure and day time application of two of
three stressors: a social defeat, restraint stress and tail suspension,
a combination of which was applied in a semi-random manner
(Figure 1B; Strekalova and Steinbusch, 2010; Couch et al., 2013).
Briefly, between the hours of 09:00 and 18:00 two stressors per
day were employed in the following sequence: social defeat for
30min, restraint stress for 2 h and tail suspension for 40min with
an inter-session interval of at least 4 h. This procedure induces
anhedonia in a considerably shorter time than previously vali-
dated models by increasing the daytime stress load. Details of rat
exposure and chronic stressors can be found in supplementary
materials.
Sleep rebound paradigm and EEG recording: One week after
the termination of stress procedure, another fraction of vehicle-
injected control and chronically stressed animals received surgi-
cally implanted electrodes. Animals were anaesthetized using a
ketamine-xylazine mixture (respectively, 4 and 75mg/kg, i.p.),
placed in a stereotaxic frame and body temperature was main-
tained at 36.5–37◦C by use of a homoeothermic blanket. Two
electrodes (length, 2mm; diameter, 500μm; both stainless steel
and connected to Teflon-insulated wires) were placed into the left
and right frontal cortices (2mm lateral and anterior to Bregma
(Cespuglio et al., 1999). Two additive electrodes were placed into
the left and right parietal cortices (2mm lateral to the midline
at the midpoint between Bregma and lambda (Cespuglio et al.,
1999) for electroencephalographic recordings (EEGs). To obtain
electromyograms (EMGs), three electrodes (active length, 1mm;
diameter, 500μm, all stainless steel and connected to Teflon-
insulated iron wires) were inserted between two neck muscle lay-
ers. After placement, all electrodes were soldered to twominiature
five-pin connectors (Sei 3D, Lyon, France) and the entire assem-
bly anchored to the skull using Super-Bond glue (Sun Medical,
Co., Shiga, Japan) and dental acrylic resin (Ivoclar, Lyon, France).
Together, four electrodes were implanted within the frontal and
parietal cortex, and one electrode in the neck muscle.
After 1 week of recovery that was combined with an acclima-
tization procedure to the EEG recording chambers, where mice
were connected to recording cables and placed individually in
plastic cages in a sound-insulated room (ambient temperature,
22 ± 1◦C; light-dark cycle 12 h–12 h, water and food ad libi-
tum). Thereafter, starting at 16.00, 48-h EEG polysomnographic
recordings (Embla, Medcare, Iceland) were performed in these
mice during baseline conditions and immediately following the 6-
h rat exposure stress (from 10.00 to 16.00) as previously described
(Couch et al., 2015).
For acute predation stress, mice were introduced into spe-
cialized cylindrical containers allowing visual and odor contact
(Costa-Nunes et al., 2014), which were placed into the rat home
cage. Visual scoring of digitized EEG and EMG traces (EEG
filtering 0.5–49.9Hz and EMG filtering 15–49.9Hz) was per-
formed over 10 s bins to quantify the number and duration of
sleep-wake episodes and the circadian scheduling of sleep-wake
states as described elsewhere (Cespuglio et al., 2012; Strekalova
et al., 2015). EEG power spectra (Somnologica software, Medcare,
Iceland) were also characterized. To this end, EEG traces sam-
pled at 100Hz were subjected to fast-Fourier transformation
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FIGURE 1 | Study flows. (A) Study of the effects of Dicholine
Succinate in a chronic stress model. Abbreviations: DS, dicholine
succinate-treated; ST, sucrose test; FC, fear conditioning; T, training; R,
recall test; B, baseline; S, stress; D, day of experiment. (B) Schematic
of the 10 day chronic stress procedure. Abbreviatons: TS, tail
suspension stress; R, restraint stress; D, day; N, night Rat: rat
exposure stress. (C) Study of the effects of Dicholine Succinate in a
model of elderly depression; D: day of experiment. Abbreviations: ST,
sucrose test. (D) Study of the effects of Dicholine Succinate in naïve
mice. Abbreviations: NC, novel cage test; OM, O-maze test; FST D1,
forced swim test day 1; FST D2, forced swim test day 2; D, day of
experiment.
(256 points, computational window 2.56 s, and 50% overlap).
Spectra were averaged over 10 s bins and divided into five adjacent
bands: delta, 0.5–4Hz; theta, 4–8Hz, alpha, 8–11.5Hz, sigma,
11.5–14.5Hz; beta-1, 14.5–18.6Hz, and beta-2, 18.6–30Hz, and
expressed as percentages of total band power (0–49.9Hz).
The duration of slow wave sleep (SWS) and Rapid Eye
Movement (REM) sleep was averaged for 48-h baseline and
48-h after-challenge periods for each animal. Because of well-
known inter-individual variability in sleep parameters of rodents,
to evaluate the effects of a predation stress, the EEG data for
that period were expressed in percent from the averaged base-
line for each mouse, as described earlier (Cespuglio et al., 2012;
Strekalova et al., 2015).
STUDY DESIGN WITH MODEL OF ELDERLY DEPRESSION
In this experiment, we examined the potential effects of DS on
the consumption of palatable 1%-sucrose solution by old mice
using a two-bottle sucrose preference test. A decrease in sucrose
intake and preference over water is generally taken as a putative
sign of anhedonia in rodents (Harro et al., 2001; Willner, 2005)
Frontiers in Behavioral Neuroscience www.frontiersin.org February 2015 | Volume 9 | Article 37 | 4
Cline et al. Brain insulin receptor and depression
and was shown to be decreased in 18-month-old C57BL6 mice;
imipramine and the neuroprotective drug dimebon were shown
to reverse this deficit (Malatynska et al., 2012). It was investigated
whether DS administered to 18-month-old mice (n = 9) for 1
week at the dose 25mg/kg/day would affect the parameters of the
sucrose preference test, in comparison with a group of mice of the
same age that did not receive such a treatment (n = 8). The dose
of DS was based on previous studies with CD1 mice, in which its
administration, with the above-indicated dosing scheme, effec-
tively reduced the stress-induced decrease in sucrose intake and
preference, floating behavior and alteration of hippocampal gene
expression typical of the subgroup of mice susceptible to anhedo-
nia (Cline et al., 2012). Twenty four hours after the termination
of the sucrose test, mice were sacrificed and their hippocam-
pal formation and prefrontal cortex were isolated for subsequent
gene expression profiling using Illumina assay as described else-
where (Markova et al., 2013b; see also below and Supplementary
Material; Figure 1C).
STUDY DESIGN WITH TESTS FOR ANXIETY- AND DEPRESSIVE LIKE
BEHAVIOR IN NAïVE MICE
Three-months-old male C57Bl6J mice received normal water
(control group), imipramine (2.5 or 15mg/kg/day) or dicholine
succinate (DS, 25 or 75mg/kg/day; Buddha Biopharma Ltd,
Helsinki, Finland; both compounds were dissolved in drinking
water) for2 weeks (n = 15 in each group), and were tested for a
depressive-like behavior in a 2-day forced swim test (Malatynska
et al., 2012;Markova et al., 2013a, 2014; Costa-Nunes et al., 2015).
Prior this testing, mice that received DS at the dose 75mg/kg/day
were additionally compared with control animals in a novel cage
test (Strekalova et al., 2004; Strekalova and Steinbusch, 2010) and
elevated O-maze (Cline et al., 2012; Malatynska et al., 2012), in
order, in particular, to rule out potential confounds in the assess-
ment of floating behavior (n = 10 from each group was tested;
Figure 1D). Because other studies on mice revealed no effects at
the dose of 25mg/kg/day of DS on the parameters of anxiety and
locomotion (Cline et al., 2012), animals from the current exper-
iment treated with this dose were not examined in additional
assays.
Since previous studies revealed a decrease of hippocampal
pGSK3 beta levels to be a marker of depressive-like behavior in
a 2-day forced swim test that was preserved by an antidepres-
sant treatment including imipramine (Markova et al., 2014), we
have chosen to study whether this variable is sensitive to the
effects of DS treatment as well. Therefore mice, subjected to a
2-day FST test and received DS at the dose 75mg/kg/day, or
imipramine at the dose 15mg/kg/day or remaining untreated,
were sacrificed 10min after the second swimming session for
subsequent isolation of the hippocampus and ELISA assay (see
below and Supplementary Material, Figure 1D). An additional
group of naïve control animals that were not subjected to FST,
was sacrificed and analyzed as well.
BEHAVIORAL TESTS
Sucrose test
In order to assess the hedonic state of mice, they were given
a free choice for 8 h (between 9.00–17.00 h) of two drinking
bottles; one with 1%-sucrose solution, and another with tap
water, as described elsewhere (Strekalova et al., 2011, 2015). To
prevent possible effects of side-preference in drinking behavior,
the position of the bottles in the cage was switched after 4 h.
Special precautions have been made in order to minimize the
spillage of liquids and error of measurement during sucrose test.
The consumption of water, sucrose solution and total intake of
liquids was estimated simultaneously in the control and exper-
imental groups by weighing the bottles. Percentage preference
for sucrose was calculated using the following formula: Sucrose
Preference = [Volume of Sucrose solution/(Volume of Sucrose
solution + Volume of Water)] × 100%.
Fear conditioning test
The test procedure was adapted from a previously described pro-
tocol (Strekalova et al., 2003; Vignisse et al., 2014). The apparatus
(Evolocus LLC Tarrytown, NY, USA and Technosmart, Rome,
Italy) consisted of a transparent plastic cubicle (25 × 25 × 50 cm)
with a stainless-steel grid floor (33 rods 2mm in diameter).
A single alternating electric current (AC, 50Hz; 0.7mA) was
delivered after a 2-min acclimatization period. Freezing behav-
ior was scored by visual observation during an acclimatization
phase and a test of memory recall that was carried out 24 h
later. The freezing episode was defined by a complete lack of
movement other than respiration accompanied by the occur-
rence of a specific posture of tension with the tail in a straight
and tense position, as described previously (Fleischmann et al.,
2003; Strekalova et al., 2003; Vignisse et al., 2014). The occur-
rence of freezing behavior was assessed every 10 s for 180 s; each
10-s score was assigned to a freezing or non-freezing period,
and the percentage of time spent in freezing was calculated.
During delivery of foot shocks, the reaction of the animals was
closely observed and rated using a 3-grade score system as max-
imal (jumping and squeaking), intermediate (jumping only), or
modest (running) (Strekalova et al., 2001). After delivery of the
current, the mouse was immediately placed back in the home
cage.
Forced swim test
The Porsolt forced swim test has been used as described elsewhere
(Malatynska et al., 2012; Couch et al., 2013). Mice were subjected
to two 6-min swimming sessions spaced 24 h apart in a trans-
parent cylinder (Ø 17 cm) filled with water (+23◦C, water height
13 cm, height of cylinder 20 cm, illumination intensity 25 Lux).
Floating was defined by the absence of any directed movements of
the animals’ head and body and was scored manually; criteria of
scoring were previously validated usingNoldus EthoVision XT 8.5
(Noldus Information Technology,Wageningen, The Netherlands)
and CleverSys (CleverSys, Reston, VA, USA). Using this method,
the latency of the first episode of floating and the duration of
floating behavior were recorded during the 6-min swimming ses-
sion on the second day of the test. Latency to begin floating
was scored as time between introduction of the animal into the
pool and the first moment of complete immobility of the entire
body for a duration of >3 s. The total time spent floating was
scored for the entire duration of the test using post-test video
footage.
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Elevated O-maze
The apparatus (Technosmart, Rome, Italy), which consisted of a
circular path (runway width 5.5 cm, diameter 46 cm), was placed
20 cm above the floor. Two opposing arms were protected by
walls (height 10 cm), and the illumination strength was 5 Lux.
The apparatus was placed on a dark surface in order to reduce
reflection and maintain control over lighting conditions dur-
ing testing. Anxiety-like behavior was assessed using previously
validated parameters that were scored manually as described else-
where (Strekalova and Steinbusch, 2010; Costa-Nunes et al., 2014;
Cline et al., 2015). Mice were placed in one of the closed-arm
compartments of the apparatus. The latency of the first exit to
the anxiety-related open compartments of the maze, the total
duration of time spent therein, the number of risk assessment
exploratory events and the number of exits to the open arms were
scored during a 5-min observation period. The risk assessment
exploratory events were defined by the stretching of the head and
a body out of the area protected by the walls toward open arm
zone, combined with exploratory pose and movements, directed
to the edges of the maze. Half of the body and back limbs of a
mouse stayed in the close arm area during these events.
Novel cage test
The novel cage test was performed to assess vertical activity in a
new environment (Strekalova and Steinbusch, 2010; Couch et al.,
2013). Mice were introduced into a standard plastic cage (21 ×
21 × 15 cm) filled with fresh sawdust. The number of exploratory
rears per each minute was counted under red light during a 5-min
period.
DOSING
The current reference antidepressant treatment was selected
because of its effects in lowering the rate of stress-induced anhe-
donia over other methods of delivery and doses of antidepressants
(Costa-Nunes et al., 2012, 2014; Strekalova et al., 2013; Cline
et al., 2015). Previous experiments revealed an antidepressant-
like effect of 1-week pre-treatment with daily i.p. injections of
DS (25mg/kg/day) in CD1mice for stress-induced depressive-like
changes (Cline et al., 2012). Likewise, here DS was adminis-
trated during 7 consecutive days to young mice preceding chronic
stress or to 18-months-old mice preceding sucrose test, at the
above-indicated dose. DS, provided by Buddha Biopharma Ltd
(Helsinki, Finland), was dissolved in water for injections. The
volume of DS and vehicle injections was 0.01ml/g body weight
0.01ml/kg.
In a study of young non-stressed mice exposed to a battery of
tests for emotionality, DS was applied via drinking water at the
doses of 25 and 75mg/kg/day. In this study, imipramine (Sigma-
Aldrich, St. Louis, MO, US) was administrated via drinking as
well. It was dissolved in tap water; the solution was freshly pre-
pared every 2–3 days. Dosage for imipramine was set at 2.5 or
15mg/kg/day. Since imipramine is light sensitive, bottles were
protected by aluminum covers. The calculation of the concen-
tration of DS and imipramine in drinking water was based on
the previously evaluated mean volume of daily water consump-
tion in C57BL6J mice that was about 3.0ml and on the dosage of
treatment.
BRAIN DISSECTION AND QUANTITATIVE RT-PCR (qPCR)
Mice were killed by cervical dislocation and their brains were dis-
sected. RNA extraction was performed frommicrodissected snap-
frozen hippocampi using RNeasy RNA extraction kit with DNase
I treatment, as previously described (Qiagen, Hilden, Germany;
Couch et al., 2013; Costa-Nunes et al., 2014). Using random
primers and Superscript III transcriptase (Invitrogen, Darmstadt,
Germany), 1μg total RNA was converted into cDNA. The expres-
sion levels of NR2A and NR2B as well as the housekeeping
gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH), that
was used as a reference gene for quantification, were evaluated
with TaqMan probes and the CFX96 Real-time System (BioRad,
Hercules, CA, USA). Cycling conditions and sequences of primers
used are indicated in the Supplementary data.
ILLUMINA ASSAY
Gene expression profiling was performed using Illumina tech-
nology (Northwestern Chicago University, USA) with the hip-
pocampi obtained from 18-months old mice (drug-naïve or
treated with DS); five animals per groupwere analyzed. Total RNA
samples were hybridized to IlluminaBeadChips (MouseRef-8 v2
Expression BeadChip; Illumina, Inc. San Diego, CA, USA) which
were prepared using the IlluminaTotalPrep RNA Amplification
kit (Applied Biosystems/Ambion, Carlsbad, CA, USA); the sam-
ples were assigned to the chips in random order with the con-
straint that no two samples from the same group were assigned to
the same chip, to avoid confounding of experimental groups with
the chips. Microarray data were analyzed using standard analy-
sis procedures, which included assessment of the overall quality
of array data and statistical evaluation of differentially expressed
genes. Once the quality of array data was confirmed, the Gene
Chip Operating System (Illumina, Inc. San Diego, CA, USA) was
used to calculate signal intensities, detection calls, and their asso-
ciated P values for each transcript on the array. Gene expression
was normalized to the expression of the housekeeping gene, beta-
actin, due to its stable expression, and calculated as percent mean
of the control group of youngmice. Differences in gene expression
between groups were evaluated using unpaired two-tailed t-test.
Illumina data were imported into Partek Genomics Suite and
quantile-normalized. Arrays that appeared as outliers on PCA
were removed from the dataset. Comparisons between experi-
mental groups were carried out in Partek-GS using ANOVA with
appropriate contrasts. P-values were adjusted for multiple testing
using step-up False Discovery Rate (FDR). The following criteria
were used to select differentially expressed genes at different strin-
gency levels: Strict: FDR < 0.05 and |fold change| > 2; Medium:
FDR < 0.1 and |fold change| > 1.5; Loose: unadjusted p-value
< 0.001 and |fold change| > 1.3, Very loose: unadjusted p values
< 0.01 and no fold change threshold (only used when more strin-
gent selection criteria yielded zero or very few hits). In the current
analysis, “medium” criteria were applied.
ELISA OF pGSK3 BETA
Hippocampus was homogenized in buffer containing 10mM Tris
(pH7,4), 100mM NaCl, 1mM EDTA, 1mM EGTA, 1mM NaF,
20mM Na4P2O7, 10% glycerol, 2mM Na3VO4 in the presence
of a protease inhibitor cocktail (Sigma, USA). The GSK-3β [pS9]
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ELISA kit (Invitrogen Corporation, USA) was used for detection
and to quantify the level of GSK-3beta protein phosphorylated at
serine residue 9. After three incubations according the instruction
manual, a signal intensity provided by monoclonal capture anti-
body specific for GSK-3β that has been coated onto the wells, was
evaluated at 450 nm using a plate reader (Wallac 1420VICTOR,
USA). The results were normalized to total protein level in tissues
homogenates, which was determined by the biuret assay; bovine
serum albumin was used as a standard (for further details, see
Supplementary data).
STATISTICS
Data were analyzed with GraphPad Prism version 5.0 for
Windows (San Diego, CA). Unpaired two-tailed test was used
to compare two groups; One-Way ANOVA was used followed
by Tukey’s, or Dunnett’s post-hoc comparison tests was applied
to compare three or more groups. Repeated measurements with
non-parametric data were evaluated withWilcoxon test. The level
of confidence was set at 95% (p < 0.05) and data are shown as
mean ± SEM.
RESULTS
DOSING WITH DICHOLINE SUCCINATE PRESERVES NORMAL HEDONIC
STATUS AND FEAR CONDITIONING IN A CHRONIC STRESS PARADIGM
At the baseline, there was no difference in sucrose preference
between the groups (p > 0.05, q = 0.25, Tukey, Figure 2A).
Following a chronic stress paradigm, ANOVA revealed a sig-
nificant difference for sucrose preference [F(5, 87) = 8.608,
p < 0.0001]. Post-hoc analysis showed that only the vehicle-
treated stressed group had a significant reduction in sucrose
preference compared to controls (p < 0.001, q = 5.53,
Tukey) as well as to their DS-treated stressed counterparts
(p < 0.05, q = 4.55, Tukey, Figure 2A), indicating that
treatment with DS was able to preclude a hedonic deficit.
Sucrose preference was similar in non-treated non-stressed
mice (76.22 ± 2.84%) and DS-treated non-stressed mice
[82.01 ± 3.1; p = 0.193; t(12) = 1.381; unpaired two-tailed
t-test].
During training in the fear conditioning model, control,
vehicle-treated stressed and DS-treated stressed groups had a
similar percent of mice expressing responses to foot shock:
maximal (45, 50, and 55%, respectively), intermediate (30,
25, and 25%, respectively), and a modest response to the
foot-shock (25, 25, and 20%, respectively; p > 0.05, exact
Fischer test). Baseline rates of freezing behavior measured dur-
ing training were minimal and did not differ between the
three groups either (control vs. vehicle: p > 0.05 q = 0.25,
control vs. DS: p > 0.05, q = 2.09; data not shown, Tukey);
together, suggesting their similar behavior under untrained
conditions.
Analysis of freezing behavior during a recall session using
ANOVA and Tukey post-hoc test revealed a significant difference
between the groups [F(5, 68) = 4.724, p = 0.0009] and showed
that the vehicle-treated stressed group had significantly less
freezing as compared to their counter parts control (p < 0.01,
q = 5.56, Figure 2B) and DS-treated stressed mice (p < 0.01,
q = 5.27, Figure 2B).
EFFECTS OF DOSING WITH DICHOLINE SUCCINATE ON SLEEP
PARAMETERS OF CHRONICALLY STRESSED MICE IN ACUTE-STRESS
SLEEP REBOUND PARADIGM
A fraction of mice exposed to chronic stress, was implanted with
electrodes and, after a recovery period, was habituated to the
recording chamber and connection to the cables and then sub-
jected to a 48 h EEG registration. In order to assess the effects of
acute stress on chronically stressed mice that were either treated
with DS, or remained pharmacologically naïve, the recording pro-
cedure was interrupted for a 6-h rat exposure stress and then
re-started for another 48 h. The duration of SWS and REM sleep
was averaged for 48-h baseline and after-predation periods for
each animal. Because of well-known inter-individual variability
in sleep parameters of rodents, EEG data that were obtained after
the predation period, were expressed as percent from the averaged
baseline values.
Both groups had an increase of the duration of SWS and REM
sleep after acute predation stress in comparison to baseline val-
ues (stressed non-treated group: p = 0.0158,W = 28.0 and p =
0.0469, W=24.0, stressed DS-treated group: p = 0.0313,W =
21.0 and p = 0.0255,W = 28.0, Wilcoxon). The duration of
REM sleep, normalized to baseline, was significantly longer
in the DS-treated stressed group compared with the phar-
macologically naive stressed group [t(10) = 2.478, p = 0.0327,
unpaired two-tailed t-test]; however, no differences were seen
for SW sleep [t(11) = 0.3451, p = 0.7366, unpaired two-tailed
t-test, Figures 2C,D]. Thus, DS-treated stressed mice demon-
strated enhanced REM sleep rebound following acute stress, a
sign of adaptive stress response, in comparison with vehicle-
treated stressed animals. Power spectra analysis revealed no
changes in comparison to baseline measures in both challenged
groups (p > 0.05, Wilcoxon) and no differences between the
groups challenged with a predator stress (p > 0.05, unpaired
two-tailed t-test), during SWS nor during REM sleep stages,
as expressed in percent from initial baseline values for these
animals (Figures 2C,D; power spectra data for baseline and
after-predation conditions can be found in Supplementary
Table 2).
DOSING WITH DICHOLINE SUCCINATE PREVENTS STRESS-INDUCED
INCREASES OF mRNA OF NMDA RECEPTOR SUBUNITS IN THE
HIPPOCAMPUS OF CHRONICALLY STRESSED MICE
Since changes in the NMDA-receptormediated transmission were
shown to underlie the antidepressant effects of other neuronal
insulin sensitizers, we studied hippocampal gene expression of
NMDA receptor subunit NR2A and the ratio of NR2A/NR2B,
whose increases were previously demonstrated to accompany a
susceptibility to stress-induced anhedonia in the here applied
chronic stress model (Costa-Nunes et al., 2014). Twenty four
hours after the last behavoral test, i.e., on the 5th day after
the termination of chronic stress, in accordance with previously
established protocols (Strekalova et al., 2011; Cline et al., 2012),
animals were sacrificed for the study of hippocampal gene expres-
sion of NMDA receptor subunits. ThemRNA levels of NR2Awere
significantly increased in chronically stressed animals which were
not treated with DS following chronic stress [p < 0.05, q = 379,
Tukey, F(2,17) = 4.010, p = 0.0375, ANOVA, Figure 2E]. There
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FIGURE 2 | Effects of Dicholine Succinate in a chronic stress model.
(A) Sucrose preference was significantly lowered in stressed vehicle
treated animals as compared to their controls as well as to DS-treated
stressed mice (p < 0.001 vs. control and DS respectively). (B) In
contextual fear conditioning, the percentage of time spent with freezing
during a baseline (pre-training) period was similarly low in all experimental
groups (p > 0.05). The vehicle stressed group showed memory loss as
indicated by significantly lesser freezing compared to both non-stressed
controls (p < 0.01) and DS treated stressed mice during a recall session
that was evaluated 24 h after a baseline measurement and a training
session (+24h) p < 0.01. (C) Slow wave sleep was not different between
the not treated stressed or DS treated stressed groups (p > 0.05). Power
spectra analysis revealed no differences between the groups (p > 0.05).
(D) REM sleep was significantly increased in stressed DS treated mice
as compared to stressed not treated animals (p < 0.05); number of
animals per group as indicated above. Power spectra analysis revealed no
differences between the groups (p > 0.05). (E) mRNA expression of
NR2A, as well as the NR2A/NR2B ratio (G) were elevated in the
non-treated stress group, as compared to controls (p < 0.05, NR2A; and
p < 0.01 NR2A/NR2B ratio), but not in stressed DS-treated mice
(p > 0.05). (F) No changes were observed for NR2B mRNA expression.
Abbreviations: Con, control group; VEH, vehicle-treated; DS, dicholine
succinate-treated; B, baseline conditions; S, stressed. ∗p < 0.05 vs.
controls, #p < 0.05 vs. DS-treated group.
was no overall significant changes in the NR2B mRNA expres-
sion levels between the groups following chronic stress [F(2, 21) =
0.8881, p = 0.4264, ANOVA, Figure 2F]. Untreated stressed mice
had an increased ratio of NR2A/NR2B as compared to both con-
trols (p < 0.05, q = 4.70, Tukey) and the DS stressed groups
[p < 0.05, q = 4.62, Tukey, F(2, 17) = 7.625, p = 0.0043, ANOVA
Figure 2G].
EFFECT OF DOSING WITH DICHOLINE SUCCINATE ON SUCROSE
PREFERENCE OF OLD MICE
At the baseline, there was no difference in sucrose preference
between the groups [t(7) = 0.4509, p = 0.6657, unpaired t-test].
Animals, which did not receive treatment, aged 18 months
showed no differences in preference for sucrose [t(7) = 0.4509,
p = 0.6657, paired two-tail t-test Figure 3A] or in sucrose intake
[t(7) = 0.8845, p = 0.4058, paired two-tailed t-test, Figure 3B]
between two repeated assays of sucrose test. However, sucrose
preference and intake of sucrose was significantly increased
after dosing with DS [t(7) = 2.656, p = 0.0327, Figure 3A and
t(8) = 2.359, p = 0.0461, paired two-tailed t-test, Figure 3B;
respectively]. None of the groups showed any differences for
water intake [t(8) = 1.099, p = 0.3038, control; t(8) = 1.850,
p = 0.1015, DS, paired two-tailed t-test, Figure 3C]. Total liq-
uid consumption was also not changed in any of the groups
[t(8) = 0.8135, p = 0.4395, control; t(8) = 0.7358, p = 0.2414,
DS, paired two-tailed t-test, Figure 3D].
GENE EXPRESSION PROFILING OF THE HIPPOCAMPUS AND
PREFRONTAL CORTEX OF OLD MICE TREATED WITH DICHOLINE
SUCCINATE
Gene expression profiling of the hippocampus of DS-treated 18-
month-old mice revealed expression changes in 27 genes, in
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FIGURE 3 | Effects of Dicholine Succinate in a model of elderly
depression. (A) In 18 month aged animals, only the DS treated group
showed an increase in sucrose preference (∗p < 0.05 vs. controls) while
non-treated animals had no increased sucrose preference (p > 0.05). (B) Total
sucrose intake was not changed in animals without treatment (p > 0.05)
while DS-treated animals had an increase in total sucrose intake (∗p < 0.05
vs. controls). (C) No groups showed any difference for total water intake
(p > 0.05, not treated and p > 0.05, DS). (D) Also there were no differences
in the total liquid consumption for the not treated animals nor for the DS
treatment group (p > 0.05).
comparison to a control group, for over 1.5 fold, and FDR was
<0.1. Among these genes are those involved in neuronal synap-
tic plasticity: Arc and Nptx2, SGK1, Taf15, Vgf, Egr1, Gatad2b; all
of them were up regulated (Figure 4A, Supplementary Table 3).
Apart from them, genes encoding ascorbate transporter Slc23a3,
regulator of axonal transport Dctn1, serine protease Htra1, serine
proteases inhibitor: Slpi were up-regulated as well. The functions
of the proteins encoded by 6430548M08Rik and 6030419C18Rik
genes were not described in the literature. Functional categories of
down-regulated genes in DS-treated old animals constitute genes
that regulate sleep and circadian rhythm: Gm129, Cirbp and Dbp,
as well as ascorbate transporter Slc23a2, fatty acids transporter
Slc27a1.
As for the prefrontal cortex, four genes whose expressions were
significantly changed according to the criterion described above
were detected. One gene was up regulated (Inhba) while three
were down regulated (Figure 4B, Supplementary Table 3).
EFFECTS OF DOSING WITH DICHOLINE SUCCINATE OF NAïVE MICE:
CHANGES IN DEPRESSIVE-, ANXIETY-LIKE BEHAVIORS AND
HIPPOCAMPAL LEVELS OF PHOSPHORYLATED GSK3 BETA
In the forced swim test (FST), a One-Way ANOVA revealed no
changes between the groups in the latency to float and a signifi-
cant effect over the total time spent floating [F(4,70) = 1371, p =
0.2528; F(4,70) = 6.36, p = 0.0002, respectively; Figure 5A]. A
post-hoc Dunnett’s test showed no significant differences between
treated animals and a control group for the latency to swim,
whereas the duration of immobility was significantly decreased
in animals receiving higher doses of imipramine (15mg/kg/day)
and dicholine succinate (75mg/kg/day) in comparison with
controls (p < 0.01, q = 3.79; p < 0.05, q = 2–81, respectively;
Figure 4A). In the elevated O-maze test mice treated with a dose
of 75mg/kg/day of dicholine succinate, displayed significantly
longer duration in the open arms, with no significant changes to
a latency to exit, total number of exits, or risk assessment behav-
ior in comparison with control animals [p = 0.038, t(18) = 1.88;
p = 0.28, t(18) = 0.59; p = 0.15, t(18) = 1.07; p = 0.34, t(18) =
0.99, respectively; unpaired two tailed t-test; Figure 5B]. In the
novel cage test for locomotion/exploration, animals treated with
dicholine succinate exhibited unchanged number of rearings in
comparison to a control group [first minute: p = 0.61, t(17) =
0.52; second minute: p = 0.40, t(17) = 0.86; third minute: p =
0.89, t(17) = 0.13; fourth minute: p = 0.20, t(17) = 1.34; fifth
minute: p = 0.49, t(17) = 0.71; total rearings: p = 0.27, t(17) =
1.13; unpaired two-tailed t-test; Figure 5C].
A One-Way ANOVA reveals significant group differences in
the levels of phosphorylated GSK-3beta in the hippocampus of
mice subjected to the forced swim test (p = 0.0145; F = 4.130).
A post-hoc Tukey test showed a significant reduction in GSK-
3beta in untreated animals as compared with to intact control
mice (p < 0.05, q = 3.85). No such decrease was found in ani-
mals tested in the forced swim test that were treated with either
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FIGURE 4 | Gene expression profiling of brain of old mice treated with Dicholine Succinate. A significant change in over 1.5 folds from vehicle-treated
aged control as found with 27 genes in the (A)hippocampus and 4 genes in the (B) prefrontal cortex. For the criteria of gene selection, see the text.
imipramine or dicholine succinate (imipramine: p > 0.05, q =
0.21 and dicholine succinate: p > 0.05, q = 0.43; Figure 5D).
Untreated animals subjected to the forced swim test had sig-
nificantly lower levels of the hippocampal pGSK-3beta levels in
comparison to imipramine- and DS-treated animals (p < 0.05,
q = 3.95 and p < 0.05, q = 4.03, respectively; Tukey post-hoc
test; Figure 5D).
DISCUSSION
EFFECTS OF DICHOLINE SUCCINATE IN A CHRONIC STRESS MODEL
In the current work, stress exposure lowered sucrose preference
in agreement with other reports (Willner et al., 1987; Harro
et al., 2001; Krishnan et al., 2007). Stressed mice treated with
DS showed no significant change in sucrose preference mea-
sured after the 10th day of stress as compared to control animals
(Figure 2A), similarly to the effects of classical antidepressants
(Costa-Nunes et al., 2014; Cline et al., 2015; Strekalova et al.,
2015). Earlier, we have shown in a model of stress-induced anhe-
donia that the decrease in sucrose preference is paralleled by
a reduction in sucrose intake (Strekalova et al., 2004, 2006).
Importantly, administration of DS did not alter sucrose test
parameters in non-stressed animals ruling out any possible con-
founding artifacts for sucrose test measurements which could be
related to treatment. Thus, the partial preclusion of the stress-
induced reduction for sucrose preference by treatment with DS
manifests their antidepressant-like activity in our study that is in
line with previous findings obtained in a similar model on CD1
mice (Cline et al., 2012).
Treatment with DS prevented stress-induced memory impair-
ment in the fear conditioning task (Figure 2B). Similar freezing
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FIGURE 5 | Study of the effects of Dicholine Succinate in naïve mice. (A)
No differences were observed in the latency to float for any group (p > 0.05)
while there was a significant effect of total time spent floating (p < 0.005).
Tukey’s revealed that groups receiving higher treatment does had significantly
less floating (p < 0.01, imipramine and p < 0.05, DS). (B) In the elevated
O-maze test mice treated with a dose of 75mg/kg/day of dicholine succinate,
displayed significantly longer duration in the open arms, with no significant
changes to a latency to exit, total number of exits, or risk assessment
behavior in comparison with control animals (p < 0.05). (C) No changes were
observed between DS treated animals and controls at any time point
(p > 0.05, see the text) or for total rearings (p > 0.05). (D) Tukey’s revealed a
significant reduction in pGSK-3 beta for untreated animals subjected to FST
compared to naive control (p < 0.05). There was no difference for
imipramine-treated mice subjected to FST (p > 0.05) or DS-treated mice
subjected to FST (p > 0.05), in comparison with naive control group. pGSK-3
beta levels were also significantly lower in untreated animals exposed to FST
as compared to imipramine treated subjected to FST (p < 0.05) and DS
treated subjected to FST (p < 0.05) groups. Abbreviations: DS, dicholine
succinate-treated; FST, subjected to a forced swim test. *p < 0.05 vs.
controls, #p < 0.05 vs. FST non-treated group.
scores at baseline and the responses to foot shock in all exper-
imental groups suggest that the deficits, revealed here in the
contextual memory performance in mice subjected to stress and
their rescue in the DS-treated stressed animals, are unlikely to be
due to any distinct sensitivity to the foot-shock or to basal dif-
ferences in the emotionality in the groups. While a similarity in
these parameters in tested mice is a prerequisite of their unaltered
acquisition of fear conditioning, the here employed study design
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does not exclude the ameliorative effect of DS on either or both
learning phase(s), acquisition or / and consolidation of contextual
memories. Of interest, the stimulation of neuronal insulin recep-
tor is implicated both in memory acquisition and consolidation
(Moosavi et al., 2007) suggesting that DS can be involved in two
of these processes.
The effects of DS in the mouse fear conditioning paradigm,
as previously validated in our model studies of hippocampus-
dependent performance in mice (Strekalova et al., 2003; Vignisse
et al., 2014), are in line with the ameliorative effects of
DS on hippocampus- and cortex-dependent learning in step-
though, step-down and Morris water maze paradigms which this
drug exerted under pathological conditions of diverse origins
(Storozhevykh et al., 2007; Storozheva et al., 2008). Previously
reported effects of DS on increased levels of hippocampal IGF-2,
brain N-acetylaspartate/creatine, choline acetyltransferase activ-
ity (Storozheva et al., 2008; Cline et al., 2012) can attest for the
here observed memory preserving effects of DS. Interestingly,
choline acetyltransferase activity in the brain was shown to be
regulated by neuronal insulin receptor-mediated mechanisms
(Hoyer, 2003). Recent evidence for a critical role of IGF2 in
inhibitory avoidance learning and adult neurogenesis as shown
in the fear conditioning paradigm (Agis-Balboa et al., 2011;
Chen et al., 2011; Bracko et al., 2012) can additionally explain
the beneficial effects of DS on memory performance in chroni-
cally stressed mice. Finally, recently shown activation of insulin
receptor-mediated transmission a newly discovered mechanism
of augmented neurogenesis (Ziegler et al., 2014), can per-se result
in pro-neurogenetic and neuroprotective activities that are char-
acteristic for the antidepressants of various classes (Duman and
Li, 2012), and, thus, can underlie pro-cognitive and antidepres-
sant effects of DS.
In the present study, we found significantly longer duration
of REM but not SWS sleep in chronically stressed DS-treated
mice subjected to acute stress of predation (Figure 2C). It is well
established that acute stress of various natures, as for instance,
immobilization or predation, induces an adaptive effect of sleep
rebound, consisting in an increase of the REM stage of sleep and
to a lesser extent SWS, this is regarded as one of the impor-
tant anti-stress mechanisms (Cespuglio et al., 1999; Marinesco
et al., 1999; Koehl et al., 2002; Tang et al., 2007; Tiba et al.,
2008; Couch et al., 2015). It was shown that stress-induced
sleep rebound is decreased during aging (Clement et al., 2003;
Descamps and Cespuglio, 2010), development of anhedonia dur-
ing stress (Couch et al., 2015) and various neurochemical abnor-
malities associated with neuropsychiatric conditions (Bonnet
et al., 2000; Meerlo et al., 2001; Boutrel et al., 2002; Vazquez-
Palacios et al., 2004; Albu et al., 2014). While the exact functions
of each of the stages of sleep are, as yet unclear, it is claimed that
normal REM sleep is a crucial factor of memory consolidation
(Rolls et al., 2013; Barnes andWilson, 2014). Additionally, insulin
receptor mediated signaling is regarded as one of the regulatory
mechanisms of sleep (Valatx et al., 1999; Kashyap and Defronzo,
2007).
While recent studies suggest that challenging insulin receptor
mediated transmission in the brain might have long-term effects
lasting for weeks (Hoyer, 2003), we trust that the ameliorative
action of DS reported here on sleep rebound is likely to be related
to a reduced manifestations of depressive-like changes and stress
response in chronically stressed mice that was found to be ele-
vated for weeks in the model applied here when no antidepressant
therapies are used (Cline et al., 2015). At the same time, power
spectra activity was not changed in DS-treated mice (Figure 2C,
Supplementary Table 2) ruling out non-specific general changes
in EEG activity of the treatment and suggesting preserved cere-
bral homeostasis in DS-treated mice that can be compromised by
some antidepressants or aging (Cespuglio et al., 1999; Clement
et al., 2003).
Our study evidenced preventive effects of DS on stress-induced
increases of hippocampal gene expression of NMDA receptor
subunits NR2A and the NR2A/NR2B ratio (Figures 2E–G). The
increases of these measures were previously shown to accompany
elevated anxiety and occurrence of hedonic deficit during stress
(Boyce-Rustay and Holmes, 2006; Gao et al., 2010; Calabrese
et al., 2012; Costa-Nunes et al., 2014; Pochwat et al., 2014), impul-
sivity and aggression (Meyer et al., 2004; Bortolato et al., 2012),
home cage hyperactivity and a stress-induced elevation in periph-
eral concentrations of corticosterone (Longordo et al., 2009, 2011;
Huang et al., 2010b). A number of findings evidence that hip-
pocampal NR2A and NR2B subunits of the NMDA receptor
display fast kinetics in response to CORT and adverse experi-
ences, where changes in gene expression parallel rapid alterations
in total and surface protein levels as well as receptor trafficking
(Zhang et al., 1997; Tse et al., 2011; Pochwat et al., 2014) suggest-
ing that the changes reported in this study for mRNA levels of the
NMDA-receptor subunits reflect its functional alterations.
Other studies demonstrate the importance of NMDA-receptor
mediated currents in the antidepressant effects of pioglitazone,
as it was discussed above (Salehi-Sadaghiani et al., 2012), which
allows speculation that amelioration of depressive-like condi-
tions via enhancement of insulin receptor mediated signaling
by different drugs might commonly implicate glutamatergic
neurotransmission via this receptor.
EFFECTS OF DICHOLINE SUCCINATE IN A MODEL OF ELDERLY
DEPRESSION
DS-treated 18-month old mice displayed higher sucrose intake
and preference than pharmacologically naïve mice of this age,
suggesting a normalization of hedonic state by the treatment.
Comparable to these changes, similar effects were also demon-
strated for treatment with imipramine or the neuroprotective
drug dimebon (Malatynska et al., 2012). There was a non-
significant reduction of water intake in the DS-treated group that
was obviously accounted for compensatory changes in drink-
ing behavior, while total liquid intake was not altered by the
treatment (Figures 3A–D). Together, the current findings may be
interpreted as a manifestation of an antidepressant-like activity of
DS in a model of elderly depression that is in line with previous
reports showing that chronic administration of DS counteracts
the development of aging-related neurochemical and cognitive
deficits in mice (Storozheva et al., 2008) and preserves normal
sucrose preference in chronically stressed mice.
Interestingly, Illumina gene expression study showed that
among 27 significantly changed genes in accordance to the
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criterion applied here, 17 were up-regulated: 7 genes from this
cohort (41.2%) constituted genes encoding factors of synap-
tic plasticity (Figure 4A and Supplementary Table 3A). These
functions are well established for most of them, such as for
immediate early gene Arc, whose activity is regulated by stim-
ulation of insulin receptor in neurons (Kremerskothen et al.,
2002; Chen et al., 2014), suppressed by chronic stress (Elizalde
et al., 2008, 2010) and increased by antidepressants (Alme et al.,
2007; Molteni et al., 2008), immediate-early gene Nptx2 encod-
ing neuronal activity-regulated pentraxin (Narp) that modulates
AMPA-receptor functions (O’Brien et al., 1999; Chang et al.,
2010), SGK1, which regulates hippocampal postsynaptic density-
95 and dendritic growth (Ma et al., 2006; Yang et al., 2006). Also,
TAF15 was shown to be implicated in the trafficking of NMDA
glutamate receptor (Ibrahim et al., 2013). VGF and Egr1 were
found to enhance hippocampal synaptic plasticity and neuro-
genesis (Thakker-Varia and Alder, 2009). GATAD2B was shown
to be required for normal cognitive performance and synapse
development (Willemsen et al., 2013).
Another cohort of altered genes in DS-treated mice whose
function is well established constitute genes that are involved in
the regulation of sleep and circadian activity. These genes include
Gm129, a novel regulator of the feedback loop that involves acti-
vators and suppressors of circadian regulation (Annayev et al.,
2014), Cirbp, a factor of cytokine-regulated expression of clock
genes (Lopez et al., 2014) and Dbp, a putative clock-controlled
transcription factor, which is increased under sleep deprivation
(Wisor et al., 2002).
Remarkably, many of these altered genes are functionally asso-
ciated with insulin receptor signaling. As for instance, activa-
tion of Arc is regulated by insulin receptor in neurons through
IRS/Grb2/Raf/Mek/Erk pathway (Kremerskothen et al., 2002);
Sgk1 is encoding a kinase that is activated by insulin via PI3-
kinase (Lang et al., 2010). Vgf is encoding a neuropeptide, which
expression is up regulated by BDNF and insulin (Salton et al.,
2000; Busse et al., 2012); Rsg4 plays a role as a negative reg-
ulator of insulin-stimulated GLUT4 translocation in adipocytes
(Kanzaki et al., 2000). Finally, Htra1 is encoding a protease that
regulates the availability of insulin-like growth factors (IGFs)
by cleaving IGF-binding proteins (Zumbrunn and Trueb, 1996);
FosB is encoding a transcription factor, which its periphery
expression is up-regulated by insulin (Coletta et al., 2008).
Notably, DS evoked limited changes in gene expression in the
prefrontal cortex. Among four genes, whose expression was sig-
nificantly changed in this study is at least one factor that was
shown to be implicated in the morphological plasticity of the
brain and antidepressant response. Inhba encodes a beta A sub-
unit that is shared by glycoprotein families Activins and Inhibins,
that were shown to have opposite functions concerning antide-
pressant mechanisms (Ganea et al., 2012). Activin A, the homod-
imer of beta A, was shown to exert and acute antidepressant-like
effect and increase the formation of synaptic contacts by modu-
lating the dynamics of actin in the neuronal spines (Shoji-Kasai
et al., 2007; Ganea et al., 2012). Expression of other genes belong-
ing to various classes of regulators whose functions in the CNS are
not well defined are associated with autophagy (Gabarapl1), other
structural functions (Opalin) and myelin organization (Stmn4)
were also significantly changed. Other significantly altered genes
encode molecules whose functions in the brain are not well
defined and mostly associated with structural functions and
myelin organization (Figure 4B and Supplementary Table 3B).
While gene expression profiling data in this study need ver-
ification using additional methods, it is remarkable that many
changes are associated with activation of brain plasticity fac-
tors and changes in sleep/circadian regulation that are known
to be implicated in the pathogenesis of depression and antide-
pressant treatment (Mellman et al., 2002; Wainwright and Galea,
2013). Moreover, a number of highlighted gene changes were also
shown to affect the elements of insulin receptor-mediated signal-
ing that could be expected with the use of compounds that like
DS stimulate this processes.
EFFECTS OF DICHOLINE SUCCINATE ON BEHAVIOR AND
HIPPOCAMPAL pGSK3 BETA IN NAïVE MICE
While the effects of either treatment on the latency to the first
episode of floating were not significant, mice treated with higher
doses of imipramine and DS had significantly shorter dura-
tion of this behavior (Figure 5A). This is in line with recent
findings treated with DS via food and tested in the tail suspen-
sion and FST and together suggests that this treatment dimin-
ishes the symptoms of learned helplessness (Costa-Nunes et al.,
2015). Coinciding with these results, another insulin sensitizer,
rosiglitazone, was reported to reduce immobilization and float-
ing behaviors in mouse tail suspension and forced swim tests
respectively (Eissa Ahmed and Al-Rasheed, 2009). Such effects
well documented for other antidepressants and are regarded as
a manifestation of antidepressant-like activity (Porsolt and Papp,
1998; Willner, 2005).
Treatment with DS decreased anxiety scores as shown by
increased time spent in the open arms of the elevated O-maze
indicating its anxiolytic and anti-stress effect (Figure 5B). Such
effects are well documented for compounds with anxiolytic activ-
ity (Willner, 2005). Elevated anxiety was found to parallel induc-
tion of a depressive-like syndrome (Willner et al., 1987; Willner,
2005; Krishnan et al., 2007; Strekalova et al., 2011). No changes
in vertical activity were found in the DS-treated group at no time
period of the observation in the novel cage test, suggesting a lack
of general effects on locomotion and a specificity of the above-
described effects on measures of depression- and anxiety-like
behaviors (Figure 5C).
Because on one hand, insulin, via the IRS/PI3K/Akt pathway,
regulates GSK3-beta activity (Cross et al., 1995) and on another
hand, mice exposed to a two-day forced swimming revealed
decreased hippocampal levels of phosphorylated at Ser9 (inactive)
form of GSK3beta (Markova et al., 2014), we assessed potential
effects of DS on the latter measure as well. We found that DS at
the dose in which it exerted an antidepressant effect in this test,
precluded stress-induced reduction of pGSK3 beta in this study
that was comparable to the effect of imipramine. The present
finding is in line with an inhibitory effect of insulin on GSK3-
beta activity. Given accumulating evidence for similar effects of
other antidepressant interventions and, in general, for the role
of elevated function of GSK3-beta in promoting mood disor-
ders and neurodegeneration (Doble and Woodgett, 2003; Li and
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Jope, 2010), these results suggest that the above-described effects
on pGSK3beta can underlie an antidepressant and pro-cognitive
action of DS. As GSK3-beta plays a key role in the induction of
NMDA-receptor-dependent LTD (Peineau et al., 2009; Bradley
et al., 2012) the effects of DS on hippocampal gene expression
of NR2A subunit of this receptor can be related to the changes in
the pGSK3 levels in this study.
CONCLUSIONS
Although a link between DS treatment and its mechanism of
action in the distinct mouse models applied here remains to
be determined, the present study argues for the potential of DS
to generate an antidepressant-like effect in various conditions,
including those in which the mechanisms of action of other sen-
sitizers of the insulin receptor are effective. A lack of signs of
toxicity of choline succinate in mammals (Shivapurkar et al.,
1986; Maekawa et al., 1990) at the dosage ranges of DS found
effective in our study favors its potential practical use.
We conclude that the insulin receptor sensitizer DS ame-
liorates depressive-like features in mice whose induction was
associated with chronic stress as well those which were not. In a
model of stress-induced anhedonia, DS preserved normal contex-
tual fear conditioning, hippocampal gene expression of NMDA
receptor subunit NR2A, the NR2A/NR2B ratio and increased
REM sleep rebound after acute predation. In a model of elderly
depression, DS restored normal sucrose preference and altered
gene expression of 27 genes of the hippocampus and the pre-
frontal cortex most of which are involved in brain plasticity
and sleep/circadian regulation. Finally, young DS-treated C57BL6
mice had reduced signs of learned helplessness through low-
ered scores of floating, similarly to the imipramine-treated group.
Also, like imipramine-treated mice, DS-treated mice demon-
strated preserved hippocampal levels of the phosphorylated
(inactive) form of GSK3 beta that was lowered by forced swim-
ming in pharmacologically naïve animals. Thus, even though a
variety of experimental techniques and determined physiological,
behavioral and molecular read-outs of a depressive-like state dose
not quite allow a connection these findings to each other, they all
point toward an antidepressant-like role for DS at different lev-
els and in different contexts. Consequently, this further highlights
the enhancement of insulin receptor signaling as a potential target
of pharmacotherapy of depressive disorder, while exactly how this
mechanism results due to the effects of DS reported here, remains
to be discovered.
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